Pharmacotherapy of oral mucosal manifestations of chronic graft-versus-host disease: When? What? and How?

References

• Treister N , Duncan C , Cutler C , et al. How we treat oral chronic graft-versus-host disease. Blood. 2012;120:3407–3418.
   PubMed Web of Science ®Google Scholar
• Elad S , Zadik Y , Caton JG , et al. Oral mucosal changes associated with primary diseases in other body systems. Periodontol 2000. 2019;80:28–48.
   PubMed Web of Science ®Google Scholar
• Fall-Dickson JM , Pavletic SZ , Mays JW , et al. Oral complications of chronic graft-versus-host disease. J Natl Cancer Inst Monogr. 2019;2019:lgz007.
   PubMedGoogle Scholar
• Kuten-Shorrer M , Woo SB , Treister NS. Oral graft-versus-host disease. Dent Clin North Am. 2014;58:351–368.
   PubMedGoogle Scholar
• Elad S , Zadik Y , Zeevi I , et al. Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplant. 2010;90:1243–1244.
   PubMed Web of Science ®Google Scholar
• Zadik Y. Restricted mouth opening in chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:201–202.
   PubMed Web of Science ®Google Scholar
• Elad S , Zadik Y , Yarom N . Oral Complications of Nonsurgical Cancer Therapies. Atlas Oral Maxillofac Surg Clin North Am. 2017;25:133–147.
   PubMedGoogle Scholar
• Zadik Y , Elad S , Shapira A , et al. Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs budesonide. Expert Opin Pharmacother. 2017;18:235–242.
   PubMed Web of Science ®Google Scholar
• Elad S , Jensen SB , Raber-Durlacher JE , et al. Clinical approach in the management of oral chronic graft-versus-host disease (chronic GVHD) in a series of specialized medical centers. Support Care Cancer. 2015;23:1615–1622.
   PubMed Web of Science ®Google Scholar
• Park AR , La HO , Cho BS , et al. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. Am J Health Syst Pharm. 2013;70:1383–1391.
   PubMed Web of Science ®Google Scholar
• Treister N , Li S , Kim H , et al. An open-label phase II randomized trial of topical dexamethasone and tacrolimus solutions for the treatment of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2016;22:2084–2091.
   PubMed Web of Science ®Google Scholar
• Epstein JB , Raber-Durlacher JE , Lill M , et al. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease. Support Care Cancer. 2017;25:357–364.
   PubMed Web of Science ®Google Scholar
• Bojanic I , Mravak Stipetic M , Pulanic D , et al. Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease. Transfusion. 2018;58:1494–1499.
   PubMed Web of Science ®Google Scholar
• Elad S , Zadik Y , Hewson I , et al. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer. 2010;18:993–1006.
   PubMed Web of Science ®Google Scholar
• Elad S , Aljitawi O , Zadik Y . Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners. Int Dent J. in press.
   Web of Science ®Google Scholar